drugset / Trial / NCT02986100
Absorption, Metabolism, and Excretion Following a Single Oral Dose of [14C]-Rucaparib
NaSingle-groupOpen-labelOther
Summary
The purpose of this study is to characterize the mass balance, absorption, metabolism, and elimination pathways of orally administered \[14C\] rucaparib followed by cycle by cycle treatment with rucaparib continuing until disease progression or other reason for discontinuation
Timeline
- Start
- 2016-11
- Primary completion
- 2017-12
- Completion
- 2018-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rucaparib | Small molecule | 600 mg | Oral |